oNKo-innate is a discovery-stage biotechnology company dedicated to target identification and pre-clinical immuno-oncology drug development. With our deep understanding of Natural Killer (NK) cells, we aim to be the first to truly therapeutically harness the cancer-fighting abilities of these remarkable white blood cells.

Biotechnology

Pharmaceutical

oNKo-innate

Jai Rautela

Nicholas Huntington

Joe Cursons

The Research and Development team at oNKo-innate is focused on pioneering innovative immuno-oncology therapies by leveraging their expertise in Natural Killer (NK) cell biology. This multidisciplinary team engages in target identification, conducts pre-clinical studies, and utilizes computational biology to enhance drug design and efficacy, all aimed at advancing the company’s mission to optimize cancer treatment through NK cell therapeutics.

Research and Development

About

Team members

Other teams at oNKo-innate

Leadership Team